BeStock  
Markets › Compare › MBX vs CELC

MBX vs CELC

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MBX · MBX Biosciences$49.55 ▼ 7.23%
CELC · Celcuity$53.35 ▼ 5.26%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4291140188237Nov 24, '25May 26, '26Nov 20, '26
  • MBX +58.6%
  • CELC -47.3%

Head to head

MetricMBXCELC
Price$49.55$53.35
Change today▼ 7.23%▼ 5.26%
Market cap$2.46B$2.62B
Return, 3 months-25.4%-41.2%
Return, year to date+57.1%-46.5%
Return, 1 year+83.0%-45.3%
P/E (TTM)––
P/B5.2-35.4
P/E percentile vs own 5y26th25th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-188.7%-67.4%
Gross margin––
Operating margin––
Net margin––
Return on equity-33.7%-1,192.9%
Analyst target vs. price+98.4%+176.7%
Analyst buy share100%100%
RSI (14)4130
30-day volatility66.3%61.9%
Max drawdown, 1 year-37.6%-63.2%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CELC is the largest of the group by market value.
  • MBX has returned the most over the past year.
  • CELC has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top